Hydrochloric Acid → (S)-ethyl 6-bromo-4-oxo-1-(piperidin-3-yl)-1,4-dihydro-1,8-naphthyridine-3-carboxylate
Reaction equation
[Br:1][C:2]1[CH:3]=[C:4]2[C:9](=[N:10][CH:11]=1)[N:8]([C@H:12]1[CH2:17][CH2:16][CH2:15][N:14](C(OC(C)(C)C)=O)[CH2:13]1)[CH:7]=[C:6]([C:25]([O:27][CH2:28][CH3:29])=[O:26])[C:5]2=[O:30].Cl.O1CCOCC1>ClCCl>[Br:1][C:2]1[CH:3]=[C:4]2[C:9](=[N:10][CH:11]=1)[N:8]([C@H:12]1[CH2:17][CH2:16][CH2:15][NH:14][CH2:13]1)[CH:7]=[C:6]([C:25]([O:27][CH2:28][CH3:29])=[O:26])[C:5]2=[O:30]Participants
5
Reactant 3
Product 1
Reagents, catalysts & solvents 1
Procedure
(S)-ethyl 6-bromo-1-(1-(tert-butoxycarbonyl)piperidin-3-yl)-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylate (Intermediate 30, 10.847 g, 22.58 mmol) was taken up in dichloromethane (10 mL) and added HCl 4M in Dioxane (113 mL, 451.63 mmol) while stirring at RT for 1 h. The solvent was removed in vacuo and the residue was triturated with DCM, ether and EtOAc to give the desired product as a yellow solid. (S)-ethyl 6-bromo-4-oxo-1-(piperidin-3-yl)-1,4-dihydro-1,8-naphthyridine-3-carboxylate (8.50 g, 90%) was recovered as the HCl salt. MS (ES)(M+H)+: 381 for C16H18BrN3O3.[HCl].
Workup
- customThe solvent was removed in vacuo
- customthe residue was triturated with DCM, ether and EtOAc
Sources & evidence
- ORD record
- ord-614eafb8d6ef44d4b2873e968ba61b9d
- Source dataset
- uspto-grants-2013_10
- Patent number
- US08569484B2
Reaction notes
Loading…